Cognizant has been announced as Platinum Partner of the Life Sciences Industry Conference 2026, taking place on Thursday 22nd October at the Crowne Plaza Hotel, Santry. The partnership brings together a programme focused on the technologies, manufacturing strategies and operational developments shaping the future of pharmaceutical and life sciences production with a company working at the intersection of AI, engineering and digital transformation.

Cognizant is an AI builder and technology services provider with expertise spanning artificial intelligence, engineering, industry processes and digital transformation. Its focus is on bridging the gap between AI investment and enterprise value, developing full-stack AI solutions designed to translate technological capability into measurable business outcomes.

For pharmaceutical and life sciences manufacturing organisations, that approach is particularly relevant as companies continue to explore how digital technologies can strengthen operational performance and address complex manufacturing challenges. Cognizant works across areas including system performance, supply chain optimisation, Manufacturing 4.0 and Lab 4.0, bringing technology together with industry and process expertise.

A key part of Cognizant’s approach is its focus on the individual requirements of each organisation. Rather than applying generic technology frameworks, the company incorporates factors such as regulatory requirements, process knowledge, manufacturing science and operational constraints into the solutions it develops. This enables digital and AI capabilities to be applied within the specific environments in which pharmaceutical and biopharmaceutical manufacturers operate.

The combination of engineering expertise, industry knowledge and AI capability gives Cognizant a strong connection to the wider transformation taking place across Ireland’s life sciences sector. As pharmaceutical manufacturers continue to invest in digitalisation, automation and data-driven operations, the ability to connect new technologies with established manufacturing processes is becoming an increasingly important part of long-term operational development.

As Platinum Partner of the Life Sciences Industry Conference 2026, Cognizant will support a programme designed to bring together industry leaders and experts to examine the opportunities emerging across pharmaceutical manufacturing. Its involvement adds further perspective to discussions around AI, digital transformation and the practical application of technology within life sciences operations.

Full details and registration are available at pharmaawards.ie/conference, and subscribe to the newsletter to stay informed on further speaker announcements and agenda updates.